Research ArticleGout
Open Access
Cost-effectiveness Analysis for Genotyping before Allopurinol Treatment to Prevent Severe Cutaneous Adverse Drug Reactions
Ching-Hua Ke, Wen-Hung Chung, Yen-Hsia Wen, Yaw-Bin Huang, Hung-Yi Chuang, You-Lin Tain, Yu-Ching Lily Wang, Cheng-Chih Wu and Chien-Ning Hsu
The Journal of Rheumatology June 2017, 44 (6) 835-843; DOI: https://doi.org/10.3899/jrheum.151476
Ching-Hua Ke
From the School of Pharmacy, and Department of Public Health and Center of Excellence for Environmental Medicine, Kaohsiung Medical University; Department of Pharmacy, Kaohsiung Medical University, Chung-Ho Memorial Hospital; Department of Pediatrics, and Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan,
Taiwan.
Wen-Hung Chung
Yen-Hsia Wen
Yaw-Bin Huang
Hung-Yi Chuang
You-Lin Tain
Yu-Ching Lily Wang
Cheng-Chih Wu
Chien-Ning Hsu
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- Pirmohamed M,
- James S,
- Meakin S,
- Green C,
- Scott AK,
- Walley TJ,
- et al.
- 4.↵
- Taiwan Drug Relief Foundation
- 5.↵
- Taiwan Drug Relief Foundation
- 6.↵
- 7.↵
- Zeng M,
- Zhang M,
- Liu F,
- Yan W,
- Kong Q,
- Sang H
- 8.↵
- 9.↵
- 10.↵
- Jung JW,
- Song WJ,
- Kim YS,
- Joo KW,
- Lee KW,
- Kim SH,
- et al.
- 11.↵
- Chung WH,
- Chang WC,
- Stocker SL,
- Juo CG,
- Graham GG,
- Lee MH,
- et al.
- 12.↵
- Khanna D,
- Fitzgerald JD,
- Khanna PP,
- Bae S,
- Singh MK,
- Neogi T,
- et al;
- American College of Rheumatology
- 13.↵
- Cheng CL,
- Chao PH,
- Hsu JC,
- Weng MM,
- On AW,
- Yang YH
- 14.↵
- Kydd AS,
- Seth R,
- Buchbinder R,
- Edwards CJ,
- Bombardier C
- 15.↵
- Taiwan Drug Relief Foundation
- 16.↵
- 17.↵Mini-Sentinel modular program report: oxicam NSAIDs, modafinil/armodafinil, sulfamothoxazole & severe cutaneous adverse reaction (SCAR) events. [Internet. Accessed February 17, 2017.] Available from: www.sentinelinitiative.org/sites/default/files/Drugs/Assessments/Mini-Sentinel_Modular-Program-Report_MSY2_MP3t4_Oxicam-NSAIDs-Modafinil-Armodafinil-SMZ-SCAR_1.pdf
- 18.↵
- 19.↵
- 20.↵
- Dong D,
- Tan-Koi WC,
- Teng GG,
- Finkelstein E,
- Sung C
- 21.↵
- 22.↵
- 23.↵
- Chohan S
- 24.↵
- 25.↵
- 26.↵
- 27.↵
- Travers K,
- Martin A,
- Khankhel Z,
- Boye KS,
- Lee LJ
- 28.↵
- 29.↵
- 30.↵
- Richette P,
- Doherty M,
- Pascual E,
- Barskova V,
- Becce F,
- Castañeda-Sanabria J,
- et al.
- 31.↵
- 32.↵
- 33.↵
- 34.↵
- 35.↵
- Jordan KM,
- Cameron JS,
- Snaith M,
- Zhang W,
- Doherty M,
- Seckl J,
- et al;
- British Society for Rheumatology and British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group (SGAWG)
- 36.↵
- Frequency of adverse drug reactions
- 37.↵
- National Health Insurance Administration;
- Ministry of Health and Welfare
- 38.↵
- Yang CY,
- Chen CH,
- Deng ST,
- Huang CS,
- Lin YJ,
- Chen YJ,
- et al.
- 39.↵
- Economic Forecast Section;
- Department of Statistics;
- Directorate General of Budget, Accounting & Statistics (DGBAS)
- 40.↵
- 41.↵
- 42.↵
- Vázquez-Mellado J,
- Morales EM,
- Pacheco-Tena C,
- Burgos-Vargas R
- 43.↵
- 44.↵
- Otto MA
- 45.↵
- Abeles AM
- 46.↵
- 47.↵
- Saeed H,
- Mantagos IS,
- Chodosh J
- 48.↵
In this issue
The Journal of Rheumatology
Vol. 44, Issue 6
1 Jun 2017
Cost-effectiveness Analysis for Genotyping before Allopurinol Treatment to Prevent Severe Cutaneous Adverse Drug Reactions
Ching-Hua Ke, Wen-Hung Chung, Yen-Hsia Wen, Yaw-Bin Huang, Hung-Yi Chuang, You-Lin Tain, Yu-Ching Lily Wang, Cheng-Chih Wu, Chien-Ning Hsu
The Journal of Rheumatology Jun 2017, 44 (6) 835-843; DOI: 10.3899/jrheum.151476
Cost-effectiveness Analysis for Genotyping before Allopurinol Treatment to Prevent Severe Cutaneous Adverse Drug Reactions
Ching-Hua Ke, Wen-Hung Chung, Yen-Hsia Wen, Yaw-Bin Huang, Hung-Yi Chuang, You-Lin Tain, Yu-Ching Lily Wang, Cheng-Chih Wu, Chien-Ning Hsu
The Journal of Rheumatology Jun 2017, 44 (6) 835-843; DOI: 10.3899/jrheum.151476